Hydroxychloroquine COVID-19 study | Cardiac arrest | Immune cells protect brain

Hydroxychloroquine study results; life support machine helps cardiac arrest patients; immune cells trained in the gut protect the brain

Having trouble viewing this email? View it as a Web page. November 24, 2020 Edition  COVID-19 is an emerging, rapidly evolving situation, and we at NIH are doing everything we can toward the development of diagnostics, therapeutics, and vaccines. You can find the latest public health information from CDC at www.coronavirus.gov and the latest research information from NIH at www.nih.gov/coronavirus. Meanwhile, science continues to progress on many other fronts, and we will continue to try to bring you stories across a wide range of topics. Hydroxychloroquine doesn't benefit hospitalized COVID-19 patients In a final analysis of study data, researchers concluded that the medication hydroxychloroquine provides no benefit to adults hospitalized with COVID-19. Life support machine helps cardiac arrest patients survive Using a life support machine called ECMO shortly after cardiac arrest outside of a hospital improved patients' chances of survival. Immune cells trained in the gut protect the brain Researchers found that the brain's protective membranes are guarded against microbes by immune cells that are trained in the gut. Popular Stories: Final report confirms remdesivir benefits for COVID-19 Experimental coronavirus vaccine is safe and produces immune response Immune cells for common cold may recognize SARS-CoV-2    New inflammatory disease discovered  Potent antibodies found in people recovered from COVID-19  Connect with us:  Facebook RSS Feed

Update Your E-mail Address | Add Subscriptions | Unsubscribe All If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com. For all other inquiries about NIH programs and activities, please contact Ask NIH. Before writing, please view our Frequently Asked Questions page, our Health Information page, or Search our website. This service is provided to you by the National Institutes of Health. NIH…Turning Discovery Into Health®

---

This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institutes of Health (NIH) · 9000 Rockville Pike · Bethesda MD 20892 · 301-496-4000 / TTY 301-402-9612